If your tomorrow will be an exact repetition of today, and you aren’t happy today, you are sure up for even tomorrow and the coming tomorrow like one of the poem has discussed about the tantrums of a human it's somewhere like : "On your body thin like paper, O worker! How much burden have you borne. Not the load of one, two, four, eight, or ten months; All twelve
months have you balanced on your body."
If you are searching for you. then you are at the right place, here we are providing free of cost. The LHC method operates to enhance the consistency of answers Even though the LHC has been utilized to measure patterns of substance use among various groups,18,20,24-26 to our knowledge, the feasibility of administration within a population of long term chronic opioid users hasn't been investigated. Drug use and treatment variables evaluated in combination with the LHC and over a lifetime reference period with one another could show patterns and underlying mechanisms that have strong consequences for the supply of care for women and men fighting with opioid addiction.
This paper aims to describe the used when gathering data using the LHC in a sample of individuals with long term opioid dependency and to identify specific
factors that affect the feasibility of distributing the interview. Further, the paper aims to go over the potential function of the LHC in addiction research. Procedures
The LHC was collected as part of an illustrative mixed-process cross-sectional pilot study. The GeMa (gender matters in the health of long-term opioid injectors) study
aimed to identify gender-specific patterns in drug use, victimization, accessibility to care, and physical and mental health among men and women with long term opioid
dependence. The study was conducted in Vancouver, Canada, between December 2011 and July 2013 by a research team with a consistent and longstanding presence in the
community. Recruitment strategies included referral through community-based health care organizations, other research studies using a similar target population, and
word of mouth. Inclusion criteria for GeMa consisted of the following: (a) 19 years of age or older (adult age in British Columbia); (b) residing in the greater Vancouver metropolitan area; (c) at least 5 years of opioid use before contribution; (d) routine use of illicit opioids during the six months before contribution; and (e) one or more episode[s] of methadone maintenance treatment (MMT) or another form of opioid substitution treatment (eg, Suboxone). The Providence Health Care/University of British Columbia Research Ethics Board reviewed and approved all research procedures. This research complied with the principles of the Declaration of Helsinki.